课题基金 / 基金详情

Genetic diagnosis of gliomas and its clinical application

Genetic diagnosis of gliomas and its clinical application
胶质瘤的基因诊断及其临床应用
批准号:
05454397
负责人:
HAYAKAWA Toru
金额:
$4.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

HAYAKAWA Toru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We had already made mouse monoclonal antibodies(ONS-M21) for the antigens which were shared in both glioma and medulloblastoma(Br J Cancer 68 : 831-837,1993). Then we succeed in humanization of their antibodies (Mol Immunol, in press) and their single-chained antibodies in cooperation with Chugai Pharmaceutical Co.Ltd. Using these humanized antibodies and their single-chained antibodies, we might develop the correct diagnose of tumor sites, and will try to apply to immunotherapy of malignant glioma patients. And now it is in the last steps to extract the malignant glioma-associated antigens which were recognized with these mouse monoclonal antibodies. After extraction of their antigens, we will identify their gene arrangement and mechanisms of their expression.We publishied two papers about selective expression of foreign genes in glioma cells by glial-specific promoters (Jpn J Cancer Res 83 : 1244-1247,1992 ; J Neurosci Res 38 : 415-423,1994). At present, we repeats the in vivo gene t … More herapy in mouse glioma models under these in vitro data with the mouse myelin basic protein (MBP) gene promoters to direct toxic gene expression (J Neurosci Res 36 : 472-479,1993). Then, if we could elucidate the glioma-associated antigens accordig to our plans, we will analyze the promoters controlling their manifestation and will apply them in gene therapy with tissuespecificity in the future.On the other hand, to understand the cellular mechanism of brain invasion by glioma cells, two molecular species of glioma-derived motility factor (GMF), GMF-I and GMF-II,have been purified to homogeneity from the serum-free conditioned medium of a highly invasive human glioma cell line, T98G,by gelatin affinity chromatography and heparin affinity-, DEAE-, hydroxyapatite-, gel permeation- and sulfopropyl high performance liquid chromatography. GMF-I and GMF-II both stimulated the migration of T98G cells in a concentration-dependent manner, and the activity of GMF-I was about 5 times as strong as that of GMF-II.C_6 glioma cells, both of which showed high invasiveness in an in vitro invasion assay with reconstituted basement membrane, Matrigel, migrated to the GMFs with great intensity, while A172 and 9L glioma cells and normal glial cells, all of which weakly infiltrated the Matrigel barrier, migrated to the GMFs with much less intensity. These results indicate that migratory response of glioma cells to the GMFs correlates well with invasiveness, suggesting an important roles of the GMFs in the process of glioma cell invasion (Biochem Biophys Res Commun 193 : 518-525,1993). Less
期刊论文(66)
专著(0)
科研奖励(0)
会议论文
Takai T: "Anti-proliferative effects of TNP-470 on human malignant glioma in vivo:potent inhibition of tumor angiogenesis." J Neuro-Oncol. 19. 251-258 (1994)
Takai T:“TNP-470 对人体内恶性神经胶质瘤的抗增殖作用:有效抑制肿瘤血管生成。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamada M,et al: "Migration of genetically labeled glioma cells after inplantation into murine brain." J Neurosci Res. 38. 415-423 (1994)
Yamada M 等人:“基因标记的神经胶质瘤细胞植入小鼠大脑后的迁移。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ohnishi T: "Purification of motility factor(GMF)from human malignant glioma cells and its biological significance in tumor invasion." Biochem Biophys Res Commun. 193. 518-525 (1993)
Ohnishi T:“从人恶性胶质瘤细胞中纯化运动因子(GMF)及其在肿瘤侵袭中的生物学意义。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Moriuchi S: "Characterization of a new mouse monoclonal antibody(ONS-M21)reactive with both medulloblastomas and gliomas." Br J Cancer. 68. 831-837 (1993)
Moriuchi S:“一种与髓母细胞瘤和神经胶质瘤均具有反应性的新型小鼠单克隆抗体 (ONS-M21) 的表征。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
30
    Basic research to design "Order-made" Cry toxin
    • 批准号:
      20380036
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2008
    • 负责人:
      HAYAKAWA Toru
    • 依托单位:
    Development of computer assisted neurosurgical techniques with reconstructed cerebral surface anatomical images for presurgical planning and image guided localization
    • 批准号:
      06557080
    • 项目类别:
      Grant-in-Aid for Developmental Scientific Research (B)
    • 资助金额:
      $1.28万
    • 财政年份:
      1994
    • 负责人:
      HAYAKAWA Toru
    • 依托单位:
    Purification of ischemia induced neurotrophic factor and its application to the vascular dementia
    • 批准号:
      02670628
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1990
    • 负责人:
      HAYAKAWA Toru
    • 依托单位:
    Development of the Computer Assisted Neurosurgery (CANS)
    • 批准号:
      01870063
    • 项目类别:
      Grant-in-Aid for Developmental Scientific Research (B).
    • 资助金额:
      $1.34万
    • 财政年份:
      1989
    • 负责人:
      HAYAKAWA Toru
    • 依托单位:
    海外基金